"Health & Medical News"

Washington — Drug firms would have a more direct route to physicians when it comes to spreading the word about new research findings for off-label uses of drugs and devices, if a new Food and Drug Administration proposal is finalized.

The proposal, which was published in the Feb. 20 Federal Register Read the rest of this entry »

Popularity: unranked [?]

Washington — Cancer patient Judith M. Layzer has come to the conclusion that the administrators of the Medicare drug benefit are forcing her to choose between her money and her life.

Layzer, a 66-year-old retired widow from New York, has a granulosa cell tumor, a rare form of ovarian cancer that no longer responds to the more traditional treatments for the condition. So for the past eight years, her doctor has had her on daily doses of Cetrotide (cetrorelix acetate), a drug that is normally used to prevent premature ovulation in women undergoing fertility treatments. She and her doctor are convinced that this off-label use of the drug has kept her alive.

Read the rest of this entry »

Popularity: unranked [?]